EUVIMEDEUVIMED entdecken
Multizentrische Studie

Outcomes of patients undergoing Optilume® drug-coated balloon for different locations of urethral strictures: results from a multicenter cohort

Lea Seiler, Giovanni Lorenzo De Giorgi, Guglielmo Mantica, Leonidas Karapanos, Pascal Viktorin, Yusuf Ahmed, Sarah Clements, Alexander Güdemann, Daniele Jonusaite, Kerem Gerritsen, Svetozar Subotic, Maciej Kwiatkowski und 3 weitere

World Journal of Urology · 21.06.2026 · 44 (1)

DOI: 10.1007/s00345-026-06547-2 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift World Journal of Urology, online erschienen am 21.06.2026. Verfasst von Lea Seiler und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kantonsspital Aarau, Aarau, Switzerland. Hauptthemen laut MEDLINE: Urethral Stricture, Paclitaxel, Dilatation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Optilume® drug-coated balloon (DCB), combining mechanical dilation with localized paclitaxel delivery, is a novel minimally invasive treatment for urethral stricture disease. However, data on its effectiveness across different stricture locations are limited. This study evaluates functional outcomes following treatment for different strictures locations. This retrospective multicenter study included patients treated with Optilume® DCB for urethral strictures at five European tertiary care referral centers (June 2023 - June 2025). Stricture length was assessed by retrograde urethrography, cystoscopy, or both. Recurrence was defined as any symptomatic stricture requiring treatment. A multivariable logistic regression using preoperative data was developed to predict recurrence requiring treatment. In total 86 patients were included across four stricture locations: penile (n = 11, 13%), bulbar/penobulbar (n = 59, 68%), bulbomembranous/membranous (n = 13, 15%) and bladder neck (n = 3, 4%). Postoperative complications within 30 days occurred in 5 (5.8%) patients. Median follow-up duration ranged from 3 to 11 months. Median peak urinary flow increased from 3.5 to 8.8 mL/s preoperatively to 13.5–19 mL/s at 3 months. Stricture-free rates were highest in penile (91%) and bladder neck (100%) strictures, and lower for bulbar (74%) and bulbomembranous/membranous (69%) strictures. On multivariate logistic regression analysis, diabetes was an independent predictor of stricture recurrence (OR = 7.66, 95% CI 1.55–47.12, p = 0.01). Optilume® DCB showed encouraging efficacy and safety across different urethral stricture locations, achieving high stricture-free rates and improved urinary flow. Diabetes independently predicted recurrence, highlighting the value of optimizing modifiable risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urethral StricturePaclitaxelDilatationMaleRetrospective StudiesHumansTreatment OutcomeMiddle AgedAgedRecurrenceCoated Materials, Biocompatible

Stichwörter der Autor:innen

Balloon-dilatationOptilumeOutcomesUrethral stricture

Substanzen

PaclitaxelCoated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Urology, Kantonsspital Aarau, Aarau, Switzerland.
  • Department of Urology, Kantonsspital Baselland, Liestal, Switzerland.
  • Department of Surgical and Diagnostic Integrated Science (DISC), University of Genoa, Genoa, Italy.
  • Department of Urology, Klinikum Leverkusen, Leverkusen, Germany.
  • Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Medical Faculty, University of Basel, Basel, Switzerland.

Zitieren

APA

Seiler, L., De Giorgi, G. L., Mantica, G., Karapanos, L., Viktorin, P., Ahmed, Y., Clements, S., Güdemann, A., Jonusaite, D., Gerritsen, K., Subotic, S., Kwiatkowski, M., Sauer, A., Wyler, S., & Afferi, L. (2026). Outcomes of patients undergoing Optilume® drug-coated balloon for different locations of urethral strictures: results from a multicenter cohort. World Journal of Urology, 44(1). https://doi.org/10.1007/s00345-026-06547-2

Vancouver

Seiler L, De Giorgi GL, Mantica G, Karapanos L, Viktorin P, Ahmed Y, et al. Outcomes of patients undergoing Optilume® drug-coated balloon for different locations of urethral strictures: results from a multicenter cohort. World Journal of Urology. 2026;44(1). doi:10.1007/s00345-026-06547-2

BibTeX
@article{Seiler2026,
  author = {Seiler, Lea and De Giorgi, Giovanni Lorenzo and Mantica, Guglielmo and Karapanos, Leonidas and Viktorin, Pascal and Ahmed, Yusuf and Clements, Sarah and Güdemann, Alexander and Jonusaite, Daniele and Gerritsen, Kerem and Subotic, Svetozar and Kwiatkowski, Maciej and Sauer, Andreas and Wyler, Stephen and Afferi, Luca},
  title = {Outcomes of patients undergoing Optilume® drug-coated balloon for different locations of urethral strictures: results from a multicenter cohort},
  journal = {World Journal of Urology},
  year = {2026},
  volume = {44},
  number = {1},
  doi = {10.1007/s00345-026-06547-2}
}
Kostenlos starten →